In women undergoing IVF, ganirelix and leuprolide regimens showed no differences in clinical, ongoing, delivered pregnancy rates or implantation rates.
In plain wordsIn women undergoing IVF, pregnancy and implantation rates did not differ between ganirelix and leuprolide regimens.
- Peptide
- Ganirelix
- Outcome
- No significant changePregnancy and implantation rates
- Study
n: not reported in source
- Comparator
- Leuprolide acetate
- Outcome group
- Sex hormones and fertility · Reproductive and sexual health
- Studied dose
- Dose not stated
Source sentences
There were no differences found in clinical, ongoing, delivered pregnancy rates or implantation rates between groups.
1 context sentence(design, population, supporting numbers)
Women needing IVF for conception were randomly assigned to 300 IU of gonadotropins with ganirelix used in the follicular phase when a follicle with a 14 mm average diameter was attained vs a regimen using leuprolide acetate from the mid-luteal phase of the previous cycle.